Cat
Name
Size
Price
Action
T2235090MSH
Paraffin-Tissue-Section---Human-Colon-Tumor:-Adenocarcinoma,-MSH-
5 Slides
Ask
HCL-1217
Human MDA-MB-361 (Breast Adenocarcinoma) lysate
100 µg
Ask
E45O00065
MDA-MB-231 (Human Breast Adenocarcinoma) Whole Cell Lysate
each
Ask
CTApt-463
Anti-Human breast adenocarcinoma (MCF7) Aptamer
10 nmol
Ask
MBS9353330-01
Hamster Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) ELISA Kit
48 Well
Ask
MBS9353330-02
Hamster Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) ELISA Kit
96 Well
Ask
MBS9353330-03
Hamster Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) ELISA Kit
5x 96 Well
Ask
MBS9353330-04
Hamster Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) ELISA Kit
10x 96 Well
Ask
T2235274MSS
Paraffin-Tissue-Section---Human-Uterus-Tumor:-Adenocarcinoma,-MSS
5 Slides
Ask
T2235248MSS
Paraffin-Tissue-Section---Human-Stomach-Tumor:-Adenocarcinoma,-MSS
5 Slides
Ask
T2235206MSS
Paraffin-Tissue-Section---Human-Rectum-Tumor:-Adenocarcinoma,-MSS
5 Slides
Ask
T2235090MSS
Paraffin-Tissue-Section---Human-Colon-Tumor:-Adenocarcinoma,-MSS-
5 Slides
Ask
CO1251
Colon adenocarcinoma tissue array, including ulcer, uplift and infiltrating type adenocarcinoma, with pathology grade, TNM/Stage ( AJCC 8th edition) and MMR (MLH1/PMS2/MSH2/MSH6 2017 Ventana MMR kit) IHC results, 125 cases/125cores (core size 1.5mm), Recent Year Collection-CO1251
each
Ask
CTApt-561
Anti-Lung Adenocarcinoma Aptamer-CTApt-561
10 nmol
Ask
CTApt-560
Anti-Lung Adenocarcinoma Aptamer-CTApt-560
10 nmol
Ask
CTApt-562
Anti-Lung Adenocarcinoma Aptamer-CTApt-562
10 nmol
Ask
CO571
Colon adenocarcinoma TMA, 5 samples have matched cancer adjacent tissue samples, including pathology grade, TNM and clinical stage (reference AJCC 8th version) with MMR (MLH1/PMS2/MSH2/MSH6 2017 Ventana MMR kit) IHC results, 52 cases/ 57 cores (core size 1.5mm)Recent Year Collection -CO571
each
Ask
CO1801a
Colon cancer with matched colon tissue array, including pathology grade, with MMR (MLH1/PMS2/MSH2/MSH6 2017 Ventana MMR kit) IHC results, TNM and clinical stage, containing 90 cases of adenocarcinoma, and 90 cancer adjacent or adjacent normal colon tissue, 90 cases/180 cores, replacing CO1801-CO1801a
each
Ask
MBS4381115-01
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.02 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381115-02
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.1 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381115-03
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.1 mg (Without BSA & Azide at 1mg/mL)
Ask
MBS4381115-04
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
5x 0.1 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381115-05
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
5x 0.1 mg (Without BSA & Azide at 1mg/mL)
Ask
MBS4381117-01
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.02 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381117-02
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.1 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381117-03
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.1 mg (Without BSA & Azide at 1mg/mL)
Ask
MBS4381117-04
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
5x 0.1 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381117-05
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
5x 0.1 mg (Without BSA & Azide at 1mg/mL)
Ask
MBS4381118-01
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.02 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381118-02
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.1 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381118-03
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.1 mg (Without BSA & Azide at 1mg/mL)
Ask
MBS4381118-04
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
5x 0.1 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381118-05
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
5x 0.1 mg (Without BSA & Azide at 1mg/mL)
Ask
MBS4381119-01
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.02 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381119-02
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.1 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381119-03
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.1 mg (Without BSA & Azide at 1mg/mL)
Ask
MBS4381119-04
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
5x 0.1 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381119-05
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
5x 0.1 mg (Without BSA & Azide at 1mg/mL)
Ask
CO1506
Progressive colon adenocarcinoma, matched cancer adjacent with normal adjacent tissue array, including pathology grade, TNM /Stage ( AJCC 8th version) and MMR (MLH1/PMS2/MSH2/MSH6 2017 Ventana MMR kit) IHC results, 50 cases/150cores (core size 1.0mm) , Recent Year Collection -CO1506
each
Ask
MBS4381116-01
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.02 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381116-02
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.1 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381116-03
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.1 mg (Without BSA & Azide at 1mg/mL)
Ask
MBS4381116-04
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
5x 0.1 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381116-05
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
5x 0.1 mg (Without BSA & Azide at 1mg/mL)
Ask
CO2081b
Colon disease spectrum with normal tissue array as control, including TNM, clinical stage and pathology grade with MMR (MLH1/PMS2/MSH2/MSH6 2017 Ventana MMR kit) IHC results, containing 34 cases of adenocarcinoma, 2 carcinoid, 20 metastatic carcinoma, 5 each of adenoma and polyp, 8 hyperplasia, 10 each of inflammation, 104 cases/ 208 cores, replacing CO2081a-CO2081b
each
Ask
CO1021a
Colon cancer with colon tissue array, including pathology grade, with MMR (MLH1/PMS2/MSH2/MSH6 2017 Ventana MMR kit) IHC results, TNM and clinical stage, containing 86 cases of adenocarcinoma, 4 papillary adenocarcinoma, 7 mucinous adenocarcinoma, 2 adenoma, 1 congenital megacolon, 2 colon tissue, 102 cases/102 cores replacing CO1021-CO1021a
each
Ask
BNUB3350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350)
100 µL
Ask
BNUB2836-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836)
500 µL
Ask
BNUM3348-50
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348)
50 µL
Ask
BNUB3347-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347)
500 µL
Ask
BNUM3350-50
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350)
50 µL
Ask
BNUB3348-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348)
500 µL
Ask
BNUB2576-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576)
500 µL
Ask
BNUB2836-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836)
100 µL
Ask
CO1507
Progressive colon adenocarcinoma with matched cancer adjacent tissue array, including ulcer, uplift and infiltrating type adenocarcinoma, with pathology grade, TNM/Stage ( AJCC 8th edition) and MMR (MLH1/PMS2/MSH2/MSH6 2017 Ventana MMR kit) IHC results, 75 cases/150cores (core size 1.0mm), Recent Year Collection-CO1507
each
Ask
AP-314-U
Human Gastric Adenocarcinoma, Peptide Aptamer, unlabeled
5mg
Ask
AP-314-F
Human Gastric Adenocarcinoma, Peptide Aptamer, FITC labelled
1 mg
Ask
AP-314-B
Human Gastric Adenocarcinoma, Peptide Aptamer, Biotinylated
1 mg
Ask
BNUM2836-50
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836)
50 µL
Ask
BNUM3347-50
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347)
50 µL
Ask
94A001
E0771 breast adenocarcinoma
Vial
Ask
BNUB3348-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348)
100 µL
Ask
BNUB3347-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347)
100 µL
Ask
BNUB2576-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576)
100 µL
Ask
BNUM2576-50
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576)
50 µL
Ask
BNUB3350-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350)
500 µL
Ask
P1435-5
CA 15-3, Human Breast Adenocarcinoma
5 KU
Ask
P1435-1
CA 15-3, Human Breast Adenocarcinoma
1 KU
Ask
94AP01
E0771 breast adenocarcinoma - Premium
Vial
Ask
BNC473348-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF647 conjugate
100 µL
Ask
BNC473350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF647 conjugate
100 µL
Ask
BNC882576-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF488A conjugate
100 µL
Ask
BNC043347-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF405S conjugate
100 µL
Ask
BNC403347-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF640R conjugate
100 µL
Ask
BNC943348-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF594 conjugate
500 µL
Ask
BNC403347-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF640R conjugate
500 µL
Ask
BNCB2836-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), Biotin conjugate
500 µL
Ask
BNC942836-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF594 conjugate
500 µL
Ask
BNCB3347-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), Biotin conjugate
500 µL
Ask
BNC742836-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF740 conjugate
100 µL
Ask
BNC882576-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF488A conjugate
500 µL
Ask
BNC682836-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF568 conjugate
500 µL
Ask
BNCB2836-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), Biotin conjugate
100 µL
Ask
BNC883348-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF488A conjugate
500 µL
Ask
BNC743348-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF740 conjugate
500 µL
Ask
BNC742576-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF740 conjugate
500 µL
Ask
BNC883350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF488A conjugate
100 µL
Ask
BNC883348-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF488A conjugate
100 µL
Ask
BNC882836-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF488A conjugate
500 µL
Ask
BNC402576-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF640R conjugate
100 µL
Ask
BNC883347-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF488A conjugate
100 µL
Ask
BNC042836-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF405S conjugate
500 µL
Ask
BNC943350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF594 conjugate
100 µL
Ask
BNC942836-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF594 conjugate
100 µL
Ask
BNC403350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF640R conjugate
100 µL
Ask
BNC473350-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF647 conjugate
500 µL
Ask
BNC403348-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF640R conjugate
500 µL
Ask
BNC043348-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF405S conjugate
100 µL
Ask
BNC683348-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF568 conjugate
100 µL
Ask
BNC043347-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF405S conjugate
500 µL
Ask
BNCB2576-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), Biotin conjugate
100 µL
Ask
BNCB3350-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), Biotin conjugate
500 µL
Ask
BNC883347-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF488A conjugate
500 µL
Ask
BNC942576-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF594 conjugate
500 µL
Ask
BNC403350-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF640R conjugate
500 µL
Ask
BNCB3348-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), Biotin conjugate
500 µL
Ask
BNCB2576-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), Biotin conjugate
500 µL
Ask
BNC742576-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF740 conjugate
100 µL
Ask
CO2085a
High-density (205 cases/208 cores), multiple type colon adenocarcinoma tissue array with normal colon from autopsy and cancer adjacent tissue, including pathology grade with MMR ( MLH1/PMS2/MSH2/MSH6 2017 Ventana MMR kit) IHC results, 208 cases/208 cores, replaced by CO2085b-CO2085a
each
Ask
BNC742836-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF740 conjugate
500 µL
Ask
BNC042836-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF405S conjugate
100 µL
Ask
BNC743348-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF740 conjugate
100 µL
Ask
BNC743350-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF740 conjugate
500 µL
Ask
BNC943348-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF594 conjugate
100 µL
Ask
BNC942576-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF594 conjugate
100 µL
Ask
BNC043348-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF405S conjugate
500 µL
Ask
BNCB3348-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), Biotin conjugate
100 µL
Ask
BNC743347-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF740 conjugate
500 µL
Ask
BNC472836-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF647 conjugate
500 µL
Ask
BNC042576-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF405S conjugate
500 µL
Ask
BNC683350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF568 conjugate
100 µL
Ask
BNC683350-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF568 conjugate
500 µL
Ask
BNC682576-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF568 conjugate
500 µL
Ask